Capital Expenses of R&D. Along with the expense of preclinical research and scientific trials, drug providers incur prices by forgoing other alternatives for investment with revenue used on medical trials. All those cash prices replicate the returns the money could have earned if they were invested in other strategies. Some https://pharmaceuticalresearch34567.wikicommunications.com/4708777/the_2_minute_rule_for_pharmaceutical_research